Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jesper Løken"'
Autor:
Maria Egede Johansen, Jens-Ulrik Jensen, Morten Heiberg Bestle, Lars Hein, Anne Øberg Lauritsen, Hamid Tousi, Kim Michael Larsen, Jesper Løken, Thomas Mohr, Katrin Thormar, Pär I Johansson, Alessandro Cozzi-Lepri, Jens D Lundgren
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e81477 (2013)
Antimicrobial-induced thrombocytopenia is frequently described in the literature among critically ill patients. Several antimicrobials have been implicated, although experimental evidence to demonstrate causality is limited. We report, using a random
Externí odkaz:
https://doaj.org/article/3727d7a046364daf8633aa80e76ec551
Autor:
Theis S, Itenov, Rasmus Ehrenfried, Berthelsen, Jens-Ulrik, Jensen, Thomas A, Gerds, Lars M, Pedersen, Ditte, Strange, Katrin, Thormar, Jesper, Løken, Mads H, Andersen, Hamid, Tousi, Nanna, Reiter, Jens D, Lundgren, Morten H, Bestle
Publikováno v:
Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine. 20(1)
Intensive care unit (ICU) patients with acute kidney injury (AKI) who recover kidney function within 28 days experience less severe chronic kidney impairment and have increased long term survival. The aims of this study were to develop and validate a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cb13504e49fc28182172481501853e7c
https://pubmed.ncbi.nlm.nih.gov/29458322
https://pubmed.ncbi.nlm.nih.gov/29458322
Autor:
Jesper Løken, Katrin Thormar, Per Hjort Christensen, Peter Søe-Jensen, Mads H. Andersen, Morten H. Bestle, Jesper Grarup, Jens-Ulrik Stæhr Jensen, Thomas Mohr, Bettina Lundgren, Lars Peters, Maria Egede Johansen, Theis Skovsgaard Itenov, Anne Øberg Lauritsen, Jens D Lundgren
Publikováno v:
Open Forum Infectious Diseases. 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0000e0ac5ee8fe9e71b1834defbbe9fe
https://doi.org/10.1093/ofid/ofv133.603
https://doi.org/10.1093/ofid/ofv133.603
Autor:
Jens-Ulrik S, Jensen, Lars, Hein, Bettina, Lundgren, Morten H, Bestle, Thomas, Mohr, Mads H, Andersen, Jesper, Løken, Hamid, Tousi, Peter, Søe-Jensen, Anne Ø, Lauritsen, Ditte, Strange, John A, Petersen, Katrin, Thormar, Kim M, Larsen, Niels-Erik, Drenck, Jannik, Helweg-Larsen, Maria E, Johansen, Kristian, Reinholdt, Jens K, Møller, Bente, Olesen, Maiken C, Arendrup, Christian, Østergaard, Alessandro, Cozzi-Lepri, Jesper, Grarup, Jens D, Lundgren, A, Engquist
Publikováno v:
Jensen, J-U S, Hein, L, Lundgren, B, Bestle, M H, Mohr, T, Andersen, M H, Løken, J, Tousi, H, Søe-Jensen, P, Lauritsen, A O, Strange, D, Petersen, J A, Thormar, K, Larsen, K M, Drenck, N-E, Helweg-Larsen, J, Johansen, M E, Reinholdt, K, Møller, J K, Olesen, B, Arendrup, M C, Ostergaard, C, Cozzi-Lepri, A, Grarup, J, Lundgren, J D & for the Procalcitonin And Survival Study Group 2015, ' Invasive Candida Infections and the Harm From Antibacterial Drugs in Critically Ill Patients: Data From a Randomized, Controlled Trial to Determine the Role of Ciprofloxacin, Piperacillin-Tazobactam, Meropenem, and Cefuroxime ', Critical Care Medicine, vol. 43, no. 3, pp. 594-602 . https://doi.org/10.1097/CCM.0000000000000746
OBJECTIVE:: Use of antibiotics in critically ill patients may increase the risk of invasive Candida infection. The objective of this study was to determine whether increased exposure to antibiotics is associated with increased prevalence of invasive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25a0827528dfe161861e4087688a69bd
https://pubmed.ncbi.nlm.nih.gov/26181129
https://pubmed.ncbi.nlm.nih.gov/26181129
Autor:
Jens D Lundgren, Katrin Thormar, Thomas Mohr, Maria Egede Johansen, Kim M Larsen, Jesper Løken, Hamid Tousi, Anne Øberg Lauritsen, Lars Hein, Jens-Ulrik Stæhr Jensen, Morten H. Bestle, Pär I. Johansson, Alessandro Cozzi-Lepri
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e81477 (2013)
PLoS ONE
PLoS ONE
Background Antimicrobial-induced thrombocytopenia is frequently described in the literature among critically ill patients. Several antimicrobials have been implicated, although experimental evidence to demonstrate causality is limited. We report, usi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfe84879c2114f57e64a5833b1ecdb65
http://europepmc.org/articles/PMC3842947?pdf=render
http://europepmc.org/articles/PMC3842947?pdf=render
Autor:
Jesper Kjaer, Peter Søe-Jensen, Hamid Tousi, Morten H. Bestle, Morten Steensen, Anne Øberg Lauritsen, Nanna Reiter, Paul Christian Fjeldborg, Lars Hein, Kim M Larsen, Jens D Lundgren, Mads H. Andersen, Zoe Fox, Ditte Strange, Maria Egede Johansen, Jesper Grarup, Thomas Mohr, Klaus J. Thornberg, Jens-Ulrik Stæhr Jensen, Bettina Lundgren, Christian Østergaard, Lene Ryom Nielsen, Katrin Thormar, Jesper Løken, Niels-Erik Drenck
Publikováno v:
BMJ Open
Jensen, J-U S, Hein, L, Lundgren, B, Bestle, M H, Mohr, T T, Andersen, M H, Thornberg, K J, Løken, J, Steensen, M, Fox, Z, Tousi, H, Søe-Jensen, P, Lauritsen, A Ø, Strange, D G, Reiter, N, Thormar, K, Fjeldborg, P C, Larsen, K M, Drenck, N-E, Johansen, M E, Nielsen, L R, Ostergaard, C, Kjær, J B, Grarup, J & Lundgren, J 2012, ' Kidney failure related to broad-spectrum antibiotics in critically ill patients : secondary end point results from a 1200 patient randomised trial ', BMJ Open, vol. 2, no. 2, pp. e000635 . https://doi.org/10.1136/bmjopen-2011-000635
Jensen, J-U S, Hein, L, Lundgren, B, Bestle, M H, Mohr, T T, Andersen, M H, Thornberg, K J, Løken, J, Steensen, M, Fox, Z, Tousi, H, Søe-Jensen, P, Lauritsen, A Ø, Strange, D G, Reiter, N, Thormar, K, Fjeldborg, P C, Larsen, K M, Drenck, N-E, Johansen, M E, Nielsen, L R, Ostergaard, C, Kjær, J B, Grarup, J & Lundgren, J 2012, ' Kidney failure related to broad-spectrum antibiotics in critically ill patients : secondary end point results from a 1200 patient randomised trial ', BMJ Open, vol. 2, no. 2, pp. e000635 . https://doi.org/10.1136/bmjopen-2011-000635
Objectives To explore whether a strategy of more intensive antibiotic therapy leads to emergence or prolongation of renal failure in intensive care patients. Design Secondary analysis from a randomised antibiotic strategy trial (the Procalcitonin And
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38662cd1d0cdf3265f5a44d1fe680802
https://pubmed.ncbi.nlm.nih.gov/22411933
https://pubmed.ncbi.nlm.nih.gov/22411933
Autor:
Thomas Mohr, J Asger Petersen, Christian Østergaard, Morten Steensen, Anne Øberg Lauritsen, Paul Christian Fjeldborg, Lars Hein, Jesper Kjaer, Jesper Løken, Sine Hougaard, Pernille L. Petersen, Peter Søe-Jensen, Søren Hestad, Lasse H. Andersen, Mads H. Andersen, Klaus J. Thornberg, Katrin Thormar, Teit Mantoni, Peder Carl, Morten H. Bestle, Bettina Lundgren, Jens-Ulrik Stæhr Jensen, Bonnie Bømler, Charlotte Dahl Rossau, Hamid Tousi, Carsten B Thomsen, Kim M Larsen, Jesper Grarup, Jens D Lundgren
Publikováno v:
BMC Infectious Diseases
BMC Infectious Diseases, Vol 8, Iss 1, p 91 (2008)
Jensen, J-U, Lundgren, B, Hein, L, Mohr, T, Petersen, P L, Andersen, L H, Lauritsen, A O, Hougaard, S, Mantoni, T, Bømler, B, Thornberg, K J, Thormar, K, Løken, J, Steensen, M, Carl, P, Petersen, J A, Tousi, H, Søe-Jensen, P, Bestle, M, Hestad, S, Andersen, M H, Fjeldborg, P, Larsen, K M, Rossau, C D, Thomsen, C B, Ostergaard, C, Kjaer, J, Grarup, J & Lundgren, J D 2008, ' The Procalcitonin And Survival Study (PASS)-a randomised multi-center investigator-initiated trial to investigate whether daily measurements biomarker Procalcitonin and pro-active diagnostic and therapeutic responses to abnormal Procalcitonin levels, can improve survival in intensive care unit patients. Calculated sample size (target population): 1000 patients ', B M C Infectious Diseases, vol. 8, pp. 91 . https://doi.org/10.1186/1471-2334-8-91
BMC Infectious Diseases, Vol 8, Iss 1, p 91 (2008)
Jensen, J-U, Lundgren, B, Hein, L, Mohr, T, Petersen, P L, Andersen, L H, Lauritsen, A O, Hougaard, S, Mantoni, T, Bømler, B, Thornberg, K J, Thormar, K, Løken, J, Steensen, M, Carl, P, Petersen, J A, Tousi, H, Søe-Jensen, P, Bestle, M, Hestad, S, Andersen, M H, Fjeldborg, P, Larsen, K M, Rossau, C D, Thomsen, C B, Ostergaard, C, Kjaer, J, Grarup, J & Lundgren, J D 2008, ' The Procalcitonin And Survival Study (PASS)-a randomised multi-center investigator-initiated trial to investigate whether daily measurements biomarker Procalcitonin and pro-active diagnostic and therapeutic responses to abnormal Procalcitonin levels, can improve survival in intensive care unit patients. Calculated sample size (target population): 1000 patients ', B M C Infectious Diseases, vol. 8, pp. 91 . https://doi.org/10.1186/1471-2334-8-91
Background Sepsis and complications to sepsis are major causes of mortality in critically ill patients. Rapid treatment of sepsis is of crucial importance for survival of patients. The infectious status of the critically ill patient is often difficul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a886e45ac1c519be48d084099753484b
https://pubmed.ncbi.nlm.nih.gov/18620598
https://pubmed.ncbi.nlm.nih.gov/18620598